In a syngeneic mouse model of intracranially implanted B16-F10 melanoma cells, tumour-bearing animals were treated first with a recombinant Ad expressing the melanoma-associated antigen dopachrome tautomerase and subsequently with an oncolytic VSV expressing the same antigen in the presence or absence of MS-275. The gene discussed is DCT; the disease is melanoma.